This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Nov 15;316(19):1979-1981.

doi: 10.1001/jama.2016.15085.

Statins for Primary Prevention: The Debate Is Intense, but the Data Are Weak

Rita F Redberg^{1

2}, Mitchell H Katz^{3

4}

Affiliations

Affiliations

¹ Department of Medicine, University of California, San Francisco.
² Editor.
³ County of Los Angeles, Department of Health Services, Los Angeles, California.
⁴ Deputy Editor.

PMID: 27838702
DOI: 10.1001/jama.2016.15085

Editorial

Statins for Primary Prevention: The Debate Is Intense, but the Data Are Weak

Rita F Redberg et al. JAMA. 2016.

. 2016 Nov 15;316(19):1979-1981.

doi: 10.1001/jama.2016.15085.

Authors

Rita F Redberg^{1

2}, Mitchell H Katz^{3

4}

Affiliations

¹ Department of Medicine, University of California, San Francisco.
² Editor.
³ County of Los Angeles, Department of Health Services, Los Angeles, California.
⁴ Deputy Editor.

PMID: 27838702
DOI: 10.1001/jama.2016.15085

Erratum in

Incorrect Data in Text.
[No authors listed] [No authors listed] JAMA. 2020 Feb 18;323(7):670. doi: 10.1001/jama.2020.0372. JAMA. 2020. PMID: 32068801 No abstract available.

No abstract available

PubMed Disclaimer

Comment on

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.
US Preventive Services Task Force; Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, García FAR, Gillman MW, Kemper AR, Krist AH, Kurth AE, Landefeld CS, LeFevre ML, Mangione CM, Phillips WR, Owens DK, Phipps MG, Pignone MP. US Preventive Services Task Force, et al. JAMA. 2016 Nov 15;316(19):1997-2007. doi: 10.1001/jama.2016.15450. JAMA. 2016. PMID: 27838723

Similar articles

Statins for Primary Prevention: The Debate Is Intense, but the Data Are Weak.
Redberg RF, Katz MH. Redberg RF, et al. JAMA Intern Med. 2017 Jan 1;177(1):21-23. doi: 10.1001/jamainternmed.2016.7585. JAMA Intern Med. 2017. PMID: 27838697 No abstract available.
Use of Statins in Adults Older Than 75 Years.
Stone NJ, Blum CB. Stone NJ, et al. JAMA. 2017 Mar 14;317(10):1081. doi: 10.1001/jama.2017.0382. JAMA. 2017. PMID: 28291887 No abstract available.
Use of Statins in Adults Older Than 75 Years-Reply.
Gurwitz JH, Go AS, Fortmann SP. Gurwitz JH, et al. JAMA. 2017 Mar 14;317(10):1081. doi: 10.1001/jama.2017.0385. JAMA. 2017. PMID: 28291890 No abstract available.
Benefit/risk ratio of statins in primary prevention.
Reidenberg MM. Reidenberg MM. Clin Pharmacol Ther. 2008 Mar;83(3):498-500. doi: 10.1038/sj.clpt.6100256. Epub 2007 May 30. Clin Pharmacol Ther. 2008. PMID: 17538549 Review. No abstract available.
[Statin therapy--for whom?].
Kahri J, Syvänne M. Kahri J, et al. Duodecim. 2012;128(8):811-8. Duodecim. 2012. PMID: 22616372 Review. Finnish.

See all similar articles

Cited by

Implementing decision aids for cardiovascular disease prevention: stakeholder interviews and case studies in Australian primary care.
Bonner C, Cornell S, Pickles K, Batcup C, de Wet C, Morgan M, Greaves K, O'Connor D, Hawkes AL, Crosland P, Chapman N, Doust J. Bonner C, et al. BMC Prim Care. 2024 Feb 3;25(1):49. doi: 10.1186/s12875-023-02258-4. BMC Prim Care. 2024. PMID: 38310217 Free PMC article.
Assessment of Sex Disparities in Nonacceptance of Statin Therapy and Low-Density Lipoprotein Cholesterol Levels Among Patients at High Cardiovascular Risk.
Brown CJ, Chang LS, Hosomura N, Malmasi S, Morrison F, Shubina M, Lan Z, Turchin A. Brown CJ, et al. JAMA Netw Open. 2023 Feb 1;6(2):e231047. doi: 10.1001/jamanetworkopen.2023.1047. JAMA Netw Open. 2023. PMID: 36853604 Free PMC article.
Lipid-Lowering Trials Are Not Representative of Patients Managed in Clinical Practice: A Systematic Review and Meta-Analysis of Exclusion Criteria.
Aeschbacher-Germann M, Kaiser N, Speierer A, Blum MR, Bauer DC, Del Giovane C, Aujesky D, Gencer B, Rodondi N, Moutzouri E. Aeschbacher-Germann M, et al. J Am Heart Assoc. 2023 Jan 3;12(1):e026551. doi: 10.1161/JAHA.122.026551. Epub 2022 Dec 24. J Am Heart Assoc. 2023. PMID: 36565207 Free PMC article. Review.
Statin associated adverse reactions in Latin America: a scoping review.
Urina-Jassir M, Pacheco-Paez T, Paez-Canro C, Urina-Triana M. Urina-Jassir M, et al. BMJ Open. 2021 Oct 1;11(10):e050675. doi: 10.1136/bmjopen-2021-050675. BMJ Open. 2021. PMID: 34598987 Free PMC article. Review.
Functional principal component based landmark analysis for the effects of longitudinal cholesterol profiles on the risk of coronary heart disease.
Shi B, Wei P, Huang X. Shi B, et al. Stat Med. 2021 Feb 10;40(3):650-667. doi: 10.1002/sim.8794. Epub 2020 Nov 5. Stat Med. 2021. PMID: 33155338 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information